BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30895415)

  • 21. Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.
    Jafari-Delouei N; Naeimi-Tabiei M; Fazel A; Ashaari M; Hatami E; Sedaghat SM; Poorabbasi M; Hasanpour-Heidari S; Ghasemi-Kebria F; Salamat F; Moghaddami A; Gholami M; Bray F; Roshandel G
    Arch Iran Med; 2020 Mar; 23(3):150-154. PubMed ID: 32126782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
    Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
    J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
    Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
    Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
    Shiels MS; Engels EA; Linet MS; Clarke CA; Li J; Hall HI; Hartge P; Morton LM
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1069-78. PubMed ID: 23595542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis.
    Liu S; Semenciw R; Mao Y
    Hematol Oncol; 2003 Jun; 21(2):57-66. PubMed ID: 12802810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence.
    Cleghorn FR; Manns A; Falk R; Hartge P; Hanchard B; Jack N; Williams E; Jaffe E; White F; Bartholomew C
    J Natl Cancer Inst; 1995 Jul; 87(13):1009-14. PubMed ID: 7629870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International variations in bladder cancer incidence and mortality.
    Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
    Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
    Bahl S; Theis B; Nishri D; Marrett LD
    Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
    Franceschi S; Dal Maso L; La Vecchia C
    Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure.
    Viel JF; Fournier E; Danzon A
    Environ Health; 2010 Aug; 9():47. PubMed ID: 20691115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based incidence of lymphomas in the French Nord-Pas-de-Calais region between 2001 and 2005: Annual estimations and spatial analysis.
    Detourmignies L; Leroyer A; Ligier K; Plouvier S; Genin M
    Rev Epidemiol Sante Publique; 2019 Sep; 67(5):319-327. PubMed ID: 31327522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry.
    Gurney KA; Cartwright RA; Gilman EA
    Br J Cancer; 1999 Apr; 79(11-12):1929-34. PubMed ID: 10206316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired immune deficiency syndrome and the increase in non-Hodgkin lymphoma incidence in New Jersey from 1979 to 1996.
    Roche LM; Paul SM; Costa SJ
    Cancer; 2001 Dec; 92(11):2948-56. PubMed ID: 11753971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
    Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
    BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales.
    Gurney KA; Cartwright RA
    Hematol J; 2002; 3(2):95-104. PubMed ID: 12032871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.